Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
Authors
Keywords
-
Journal
mSphere
Volume 3, Issue 6, Pages -
Publisher
American Society for Microbiology
Online
2018-11-20
DOI
10.1128/msphere.00547-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of non- Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile
- (2018) G. Sadeghi et al. JOURNAL DE MYCOLOGIE MEDICALE
- Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes
- (2018) Shaoming Lin et al. MYCOPATHOLOGIA
- Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia
- (2018) Alexander Rosenberg et al. Nature Communications
- Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia
- (2018) Indira Berrio et al. Journal of Global Antimicrobial Resistance
- Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study
- (2017) Milène Sasso et al. MYCOSES
- Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals
- (2017) Berdieke Goemaere et al. MYCOSES
- Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins
- (2016) Francieli Chassot et al. MYCOPATHOLOGIA
- Members of the Candida parapsilosis Complex and Candida albicans are Differentially Recognized by Human Peripheral Blood Mononuclear Cells
- (2016) Eine Estrada-Mata et al. Frontiers in Microbiology
- Role of Protein Glycosylation in Candida parapsilosis Cell Wall Integrity and Host Interaction
- (2016) Luis A. Pérez-García et al. Frontiers in Microbiology
- Mechanisms of echinocandin antifungal drug resistance
- (2015) David S. Perlin Annals of the New York Academy of Sciences
- Implication of Candida parapsilosis FKS1 andFKS2Mutations in Reduced Echinocandin Susceptibility
- (2015) M. Martí-Carrizosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2015) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- The TOPCONS web server for consensus prediction of membrane protein topology and signal peptides
- (2015) Konstantinos D. Tsirigos et al. NUCLEIC ACIDS RESEARCH
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis
- (2014) Mario Fernández-Ruiz et al. CLINICAL INFECTIOUS DISEASES
- Mechanisms of Antifungal Drug Resistance
- (2014) Leah E. Cowen et al. Cold Spring Harbor Perspectives in Medicine
- Characterization of Virulence Properties in the C. parapsilosis Sensu Lato Species
- (2013) Tibor Németh et al. PLoS One
- Differential Adaptation of Candida albicans In Vivo Modulates Immune Recognition by Dectin-1
- (2013) Mohlopheni J. Marakalala et al. PLoS Pathogens
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
- (2012) M. Cuenca-Estrella et al. CLINICAL MICROBIOLOGY AND INFECTION
- Topological and Mutational Analysis of Saccharomyces cerevisiae Fks1
- (2012) Michael E. Johnson et al. EUKARYOTIC CELL
- Stage Specific Assessment of Candida albicans Phagocytosis by Macrophages Identifies Cell Wall Composition and Morphogenesis as Key Determinants
- (2012) Leanne E. Lewis et al. PLoS Pathogens
- New Fks Hot Spot for Acquired Echinocandin Resistance inSaccharomyces cerevisiaeand Its Contribution to Intrinsic Resistance ofScedosporiumSpecies
- (2011) Michael E. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin ResistanceIn Vivo
- (2011) Keunsook K. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recognition and Blocking of Innate Immunity Cells by Candida albicans Chitin
- (2011) Héctor M. Mora-Montes et al. INFECTION AND IMMUNITY
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non-albicans Candida Species: Review of the Caspofungin Database
- (2010) A. L. Colombo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
- (2010) M. Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study
- (2010) G. M. Lyon et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)
- (2009) Olivier Leroy et al. CRITICAL CARE MEDICINE
- Caspofungin-non-susceptible Candida isolates in cancer patients
- (2009) D. P. Kofteridis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida parapsilosis, an Emerging Fungal Pathogen
- (2008) D. Trofa et al. CLINICAL MICROBIOLOGY REVIEWS
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search